BioPharm Asia Appoints Independent Director
(firmenpresse) - NEW YORK, NY and TONGHUA, CHINA -- (Marketwire) -- 12/08/11 -- BioPharm Asia, Inc. (PINKSHEETS: BFAR), a producer, distributor and retailer of medical products in China, today announced appointment of independent director.
On December 8, 2011, the Company's board of directors appointed Mr. Kenneth Wong, age 47, as independent director of the Company, effective immediately.
Mr. Xiayang Hu, Chief Executive Officer of BioPharm Asia, said, "We are pleased to welcome Ken to our board. With nearly 20 years of healthcare and financial experience in serving senior management positions including President and Chief Operating Officer, we believe Ken will make wise contributions to the board's deliberations and decisions -- in leadership, strategy, management, and in operations practice. Plus his prior corporate compliance expertise, will serve our board well to meet our regulatory filing requirements."
Formerly, Mr. Wong held senior-level financial positions at Pacific Bridge Medical (1991 - 2002), were he was responsible for, and oversaw Healthcare Staffing, Specialty Pharmaceutical Distribution/Infusion Therapy and Network Management lines of business. Mr. Wong supervised the pharmaceuticals practice at Pricewaterhouse Coopers Hong Kong (2002 - 2010). Serving as a tax partner at PwC, Mr. Wong had a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients. He was integral in the company's IT, risk management, mergers and acquisitions activities.
Mr. Wong is a graduate of the University of Kentucky and is professionally affiliated with the American Institute of Certified Public Accountants, Hong Kong Society of Certified Public Accountants, and the Healthcare Financial Management Association.
BioPharm Asia, Inc. is engaged in the retail sale of medical products in China, complemented by vertically integrated supporting functions that include the cultivation of Chinese herbal medicines, pharmaceutical production and wholesale medicine distribution. For more information, please visit .
BioPharm Asia, Inc.
Gloria Fang
(86) 135-3407-3970
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.12.2011 - 14:00 Uhr
Sprache: Deutsch
News-ID 95096
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY and TONGHUA, CHINA
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 151 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioPharm Asia Appoints Independent Director"
steht unter der journalistisch-redaktionellen Verantwortung von
BioPharm Asia, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
